Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Akebia Therapeutics, Inc. (AKBA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2023 |
4
| ZUMWALT LEANNE M (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 06/08/2023 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 06/08/2023 |
4
| FRIESON RON (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 06/08/2023 |
4
| Wolf Myles (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 06/08/2023 |
4
| ADAMS ADRIAN (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 06/08/2023 |
4
| Smith Cynthia (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 06/08/2023 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 05/25/2023 |
4
| Hadas Nicole R. (SVP, Chief Legal Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 200,000 shares
@ $0
Sold 63,186 shares
@ $1.2229, valued at
$77.3k
Granted 200,000 options to buy
@ $0.41, valued at
$82k
|
|
| 05/25/2023 |
4
| Dahan Michel (SVP, COO) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 200,000 shares
@ $0
Sold 95,478 shares
@ $1.2229, valued at
$116.8k
Granted 200,000 options to buy
@ $0.41, valued at
$82k
|
|
| 05/18/2023 |
4
| Burke Steven Keith (SVP, Chief Medical Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 63,567 shares
@ $1.068, valued at
$67.9k
|
|
| 05/18/2023 |
4
| Spellman David A (SVP, CFO and Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 63,567 shares
@ $1.068, valued at
$67.9k
|
|
| 05/16/2023 |
4
| Hadas Nicole R. (SVP, Chief Legal Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 05/16/2023 |
4
| Dahan Michel (SVP, COO) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 200,000 shares
@ $0 |
|
| 03/03/2023 |
4
| Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 38,259 shares
@ $0.8775, valued at
$33.6k
Sold 47,239 shares
@ $0.8775, valued at
$41.5k
Sold 6,370 shares
@ $0.8775, valued at
$5.6k
|
|
| 03/03/2023 |
4
| Hadas Nicole R. (SVP, Chief Legal Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 5,333 shares
@ $0.8775, valued at
$4.7k
Sold 6,613 shares
@ $0.8775, valued at
$5.8k
Sold 1,088 shares
@ $0.8775, valued at
$954.7 |
|
| 03/03/2023 |
4
| Burke Steven Keith (SVP, Chief Medical Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 6,613 shares
@ $0.8775, valued at
$5.8k
Sold 6,400 shares
@ $0.8775, valued at
$5.6k
Sold 1,110 shares
@ $0.8775, valued at
$974 |
|
| 03/03/2023 |
4
| Dahan Michel (SVP, COO) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 8,058 shares
@ $0.8775, valued at
$7.1k
Sold 10,476 shares
@ $0.8775, valued at
$9.2k
Sold 1,878 shares
@ $0.8775, valued at
$1.6k
|
|
| 03/03/2023 |
4
| Spellman David A (SVP, CFO and Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 6,400 shares
@ $0.8775, valued at
$5.6k
Sold 810 shares
@ $0.8775, valued at
$710.8 |
|
| 03/01/2023 |
4
| Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 38,632 shares
@ $0.8132, valued at
$31.4k
|
|
| 03/01/2023 |
4
| Burke Steven Keith (SVP, Chief Medical Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 7,539 shares
@ $0.8132, valued at
$6.1k
|
|
| 03/01/2023 |
4
| Spellman David A (SVP, CFO and Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 7,539 shares
@ $0.8132, valued at
$6.1k
|
|
| 03/01/2023 |
4
| Hadas Nicole R. (SVP, Chief Legal Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 6,677 shares
@ $0.8132, valued at
$5.4k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Spellman David A (SVP, CFO and Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 196,200 shares
@ $0
Granted 294,300 options to buy
@ $0.63, valued at
$185.4k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/01/2022 |
4
| Burke Steven Keith (SVP, Chief Medical Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 1,147 shares
@ $0.3625, valued at
$415.8 |
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Wolf Myles (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $0.45, valued at
$9k
|
|
| 06/09/2022 |
4
| Smith Cynthia (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $0.45, valued at
$9k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|